Jun 15, 2026 06:00AM
May 21, 2026 06:01PM
May 18, 2026 04:30PM
May 14, 2026 06:30AM
May 7, 2026 06:36AM
Apr 7, 2026 07:03AM
Mar 31, 2026 06:00AM Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mar 24, 2026 07:00AM
Mar 16, 2026 08:09AM
Mar 16, 2026 08:08AM
Mar 4, 2026 07:06AM
Mar 4, 2026 07:05AM
Feb 20, 2026 07:03AM
Feb 20, 2026 07:03AM Fennec Pharmaceuticals Presents Real World Data Supporting the Integration and Clinical Use of PEDMARK® in Treating Adults with Head & Neck Cancers
Feb 12, 2026 02:26AM
Dec 9, 2025 07:02AM
Dec 9, 2025 07:00AM
Dec 2, 2025 07:02AM
Dec 2, 2025 07:01AM
Nov 26, 2025 05:59AM
Nov 19, 2025 07:03AM Fennec Pharmaceuticals completes full debt redemption
Nov 19, 2025 07:03AM
Nov 18, 2025 08:30AM
Nov 18, 2025 08:30AM
Nov 17, 2025 04:15PM
Nov 17, 2025 04:15PM
Nov 13, 2025 11:12PM
Nov 13, 2025 11:11PM Fennec Pharmaceuticals Announces Private Offering of Common Shares in Canada
Nov 13, 2025 11:07PM
Nov 13, 2025 11:07PM
Nov 13, 2025 04:08PM
Nov 13, 2025 04:08PM
Nov 13, 2025 04:01PM
Aug 14, 2025 06:08AM
Aug 11, 2025 07:12AM Fennec Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 14, 2025
May 13, 2025 06:03AM
May 8, 2025 04:17PM
Mar 10, 2025 06:03AM
Mar 6, 2025 04:22PM
Feb 7, 2025 07:00AM
Feb 7, 2025 07:00AM
Dec 20, 2024 06:16AM Fennec Pharmaceuticals (FENC) Reports Pedmarqsi Positive Recommendation by NICE for the Prevention of Cisplatin-Induced Hearing Loss in England and Wales
Dec 20, 2024 06:16AM
Dec 19, 2024 06:14AM
Dec 19, 2024 06:13AM
Dec 12, 2024 07:01AM
Nov 13, 2024 06:27AM
Nov 7, 2024 06:13AM
Oct 31, 2024 06:23AM Fennec Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 7, 2024
Oct 28, 2024 06:23AM

323,421 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All